For young, healthy people who may be wondering, “do I need a COVID booster at all?”, having one annually is sensible.

As expected, the FDA has moved quickly to grant emergency use authorisation (EUA) to two new-generation COVID-19 mRNA vaccines from Pfizer/BioNTech and Moderna, both targeting the new Omicron ...

The UK has become the first country in the world to authorise an updated COVID-19 booster vaccine directed at the Omicron variant, giving a green light to Moderna's mRNA-1273.214 shot.

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

A new COVID-19 booster from Moderna shows promising results for protecting against a new omicron subvariant, while the CDC reported a rise in RSV cases in the Southeast. The updated COVID vaccine ...

1 booster (and Moderna’s, though the TGA has not approved this one at ... Most recently we’ve faced a soup of Omicron sub-variants, including JN.1. Since JN.1 was first detected in August 2023, this ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other high growth large cap stocks. BlackRock highlighted that its portfolio managers are broadly ...

The number of COVID cases increased last week to 146. Cases had been falling in April and May and were as low as 31 at the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Score is a weekly review of the biggest stock moves and the news that drove them.